Submission for OMB Review; Comment Request; National Survey of Primary Care Physicians' Recommendations and Practice for Breast, Cervical, Colorectal, and Lung Cancer Screening, 19528-19529 [E6-5532]
Download as PDF
<![CDATA[
19528
Federal Register / Vol. 71, No. 72 / Friday, April 14, 2006 / Notices
estimated annualized burden is
summarized below.
Type of
respondents
Number of respondents
Frequency of
responses
Children (Assessment Instrument Pilot Test) ..................................
Parents (Assessment Instrument Pilot Test) ...................................
Children (Evaluation) .......................................................................
Parents (Evaluation: 1 Satisfaction Scale/6 Usage Logs) ...............
34
34
120
120
1
1
3
1
6
Total ..........................................................................................
308
........................
Request for Comments
Written comments and/or suggestions
from the public and affected agencies
are invited on one or more of the
following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and the assumptions used;
(3) ways to enhance the quality, utility,
and clarity of the information to be
collected; and (4) ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Direct Comments to OMB
Written comments and/or suggestions
regarding the item(s) contained in this
notice, especially regarding the
estimated public burden and associated
response time, should be directed to the:
Office of Management and Budget,
Office of Regulatory Affairs, New
Executive Office Building, room 1–235,
Washington, DC 20503, Attention: Desk
Officer for NIH. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and instruments, contact Dr.
Cathrine Sasek, Coordinator, Science
Education Program. Office of Science
Policy and Communications, National
Institute on Drug Abuse, 6001 Executive
Blvd, Room 5237, Bethesda, MD 20892,
or call non-toll-free number (301) 443–
6071; fax (301) 443–6277; or by e-mail
to csasek@nida.nih.gov.
Comments Due Date
Comments regarding this information
are best assured of having their full
effect if received within 30 days of the
date of this publication.
Dated: April 10, 2006.
Laura Rosenthal,
Executive Officer, National Institute on Drug
Abuse.
[FR Doc. 06–3596 Filed 4–13–06; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Public Health Service
National Institutes of Health
Submission for OMB Review;
Comment Request; National Survey of
Primary Care Physicians’
Recommendations and Practice for
Breast, Cervical, Colorectal, and Lung
Cancer Screening
SUMMARY: Under the provisions of
section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH), National
Cancer Institute (NCI), has submitted to
the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This proposed information
collection was previously published in
the Federal Register on January 20,
2006, page 3309 and allowed 60-days
for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
Estimated
number of
respondents
Questionnaire
wwhite on PROD1PC65 with NOTICES
Average time per
response
Annual hour burden
0.75
1
0.5
0.5
0.25
25.5
34.0
180.0
240.0
................................
479.50
30 days for public comment. The
National Institutes of Health may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
Proposed Collection: Title: National
Survey of Primary Care Physicians’
Recommendations and Practice for
Breast, Cervical, Colorectal, and Lung
Cancer Screening. Type of Information
Collection Request: New. Need and Use
of Information Collection: This study
will obtain current, national data on
primary care physicians’ knowledge,
attitudes, recommendations, and
practices related to screening for breast,
cervical, colorectal, and lung cancer.
There have been substantial changes in
guidelines and/or technologies for these
types of cancer screening in recent
years. The data collected in this study
will support and further NCI work in
monitoring and evaluating providers’
cancer control knowledge, attitudes, and
practices and their impact on
population health, as well as enable
monitoring of progress toward major
cancer control goals. Two
questionnaires, one covering breast and
cervical cancer screening and the other
colorectal and lung cancer screening,
will be administered by mail or
telephone to a randomly-selected
national sample of primary care
physicians. Frequency of Response: One
Time. Affected Public: Medical
practices, clinics, or other health care
organizations. Type of Respondents:
Primary Care Physicians. Burden
estimates are as follows:
Estimated
number of
responses
per respondent
Average
burden hours
per response
Estimated total
annual burden
hours
Breast & cervical cancer screening .................................................................
Colorectal & lung cancer screening .................................................................
1250
1250
1
1
0.333
0.333
416.25
416.25
Total ..........................................................................................................
........................
........................
........................
832.5
VerDate Aug<31>2005
17:29 Apr 13, 2006
Jkt 208001
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
E:\FR\FM\14APN1.SGM
14APN1
Federal Register / Vol. 71, No. 72 / Friday, April 14, 2006 / Notices
There are no Capital Costs to report.
There are no Operating or Maintenance
Costs to report.
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(a) Whether the proposed collection of
information is necessary for the
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, New Executive
Office Building, Room 10235,
Washington, DC 20503, Attention: Desk
Officer for NIH. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and instruments, contact: Dr.
Carrie Klabunde, Epidemiologist,
Division of Cancer Control and
Population Sciences, National Cancer
Institute, Executive Plaza North 4005,
6130 Executive Boulevard, Bethesda,
Maryland 20892–7344 or call non-tollfree 301–402–3362 or E-mail your
request, including your address, to:
klabundc@mail.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30-days of the date of
this publication.
Dated: April 4, 2006.
Rachelle Ragland-Greene,
National Institutes of Health, NCI Project
Clearance Liaison.
[FR Doc. E6–5532 Filed 4–13–06; 8:45 am]
BILLING CODE 4101–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
wwhite on PROD1PC65 with NOTICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
VerDate Aug<31>2005
16:37 Apr 13, 2006
Jkt 208001
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Cancer
Detection.
Date: May 5, 2006.
Time: 11 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, 6116
Executive Boulevard, Room 8125, Bethesda,
MD. (Telephone Conference Call).
Contact Person: Virginia P. Wray, PhD.,
Deputy Chief, Research Programs Review
Branch, Research Programs Review Branch,
Division of Extramural Activities, National
Cancer Institute, 6116 Executive Blvd., Room
8125, Bethesda, MD 20892–8328. 301/496–
9236. wrayv@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Spore in
Breast Cancer Review.
Date: May 16–18, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Shamala K. Srinivas, PhD.,
Scientific Review Administrator, Grants
Review Branch, Division of Extramural
Activities, National Cancer Institute, National
Institutes of Health, 6116 Executive
Boulevard, Room 8133, Bethesda, MD 20892.
301/594–1224.
Name of Committee: National Cancer
Institute Initial Review Group, Subcommittee
F—Manpower & Training.
Date: June 13–14, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Old Town Alexandria, 1767
King Street, Alexandria, VA 22314.
Contact Person: Lynn M. Amende, PhD.,
Scientific Review Administrator, Resources
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 8105,
Bethesda, MD 20892. 301–451–4759.
amendel@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Clinical
Cluster Review.
Date: June 19–21, 2006.
Time: 6 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
19529
Contact Person: Wlodek Lopaczynski,
PhD., MD, Scientific Review Administrator,
Research Programs Review Branch, Division
of Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 8133,
Bethesda, MD 20892. 301–594–1402.
lopacw@mail.nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group, Subcommittee
A—Cancer Centers.
Date: August 3–4, 2006.
Time: 1 p.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: David E. Maslow, PhD.,
Scientific Review Administrator, Resources
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 8117,
Bethesda, MD 20892–7405. (301) 496–2330.
dm65y@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: April 6, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–3568 Filed 4–13–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory Council for Human
Genome Research.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
E:\FR\FM\14APN1.SGM
14APN1
]]>Agencies
[Federal Register Volume 71, Number 72 (Friday, April 14, 2006)]
[Notices]
[Pages 19528-19529]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-5532]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Health Service
National Institutes of Health
Submission for OMB Review; Comment Request; National Survey of
Primary Care Physicians' Recommendations and Practice for Breast,
Cervical, Colorectal, and Lung Cancer Screening
SUMMARY: Under the provisions of section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National Institutes of Health (NIH),
National Cancer Institute (NCI), has submitted to the Office of
Management and Budget (OMB) a request for review and approval of the
information collection listed below. This proposed information
collection was previously published in the Federal Register on January
20, 2006, page 3309 and allowed 60-days for public comment. No public
comments were received. The purpose of this notice is to allow an
additional 30 days for public comment. The National Institutes of
Health may not conduct or sponsor, and the respondent is not required
to respond to, an information collection that has been extended,
revised, or implemented on or after October 1, 1995, unless it displays
a currently valid OMB control number.
Proposed Collection: Title: National Survey of Primary Care
Physicians' Recommendations and Practice for Breast, Cervical,
Colorectal, and Lung Cancer Screening. Type of Information Collection
Request: New. Need and Use of Information Collection: This study will
obtain current, national data on primary care physicians' knowledge,
attitudes, recommendations, and practices related to screening for
breast, cervical, colorectal, and lung cancer. There have been
substantial changes in guidelines and/or technologies for these types
of cancer screening in recent years. The data collected in this study
will support and further NCI work in monitoring and evaluating
providers' cancer control knowledge, attitudes, and practices and their
impact on population health, as well as enable monitoring of progress
toward major cancer control goals. Two questionnaires, one covering
breast and cervical cancer screening and the other colorectal and lung
cancer screening, will be administered by mail or telephone to a
randomly-selected national sample of primary care physicians. Frequency
of Response: One Time. Affected Public: Medical practices, clinics, or
other health care organizations. Type of Respondents: Primary Care
Physicians. Burden estimates are as follows:
----------------------------------------------------------------------------------------------------------------
Estimated
Estimated number of Average Estimated
Questionnaire number of responses per burden hours total annual
respondents respondent per response burden hours
----------------------------------------------------------------------------------------------------------------
Breast & cervical cancer screening.............. 1250 1 0.333 416.25
Colorectal & lung cancer screening.............. 1250 1 0.333 416.25
---------------------------------------------------------------
Total....................................... .............. .............. .............. 832.5
----------------------------------------------------------------------------------------------------------------
[[Page 19529]]
There are no Capital Costs to report. There are no Operating or
Maintenance Costs to report.
Request for Comments: Written comments and/or suggestions from the
public and affected agencies are invited on one or more of the
following points: (a) Whether the proposed collection of information is
necessary for the performance of the functions of the agency, including
whether the information shall have practical utility; (b) the accuracy
of the agency's estimate of the burden of the proposed collection of
information; (c) ways to enhance the quality, utility, and clarity of
the information to be collected; and (d) ways to minimize the burden of
the collection of information on respondents, including through the use
of automated collection techniques or other forms of information
technology.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, New Executive Office Building, Room 10235, Washington, DC
20503, Attention: Desk Officer for NIH. To request more information on
the proposed project or to obtain a copy of the data collection plans
and instruments, contact: Dr. Carrie Klabunde, Epidemiologist, Division
of Cancer Control and Population Sciences, National Cancer Institute,
Executive Plaza North 4005, 6130 Executive Boulevard, Bethesda,
Maryland 20892-7344 or call non-toll-free 301-402-3362 or E-mail your
request, including your address, to: klabundc@mail.nih.gov.
Comments Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30-days
of the date of this publication.
Dated: April 4, 2006.
Rachelle Ragland-Greene,
National Institutes of Health, NCI Project Clearance Liaison.
[FR Doc. E6-5532 Filed 4-13-06; 8:45 am]
BILLING CODE 4101-01-P
